Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Sell
30
KMTS Quote, Financials, Valuation and Earnings
Last price:
$24.39
Seasonality move
:
--
Day range:
$24.03 - $27.55
52-week range:
$13.25 - $30.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.89x
P/B ratio:
7.09x
Volume:
283.6K
Avg. volume:
393.1K
1-year change:
--
Market cap:
$1.2B
Revenue:
$59.8M
EPS (TTM):
-$2.68
Analysts' Opinion
-
Consensus RatingKestra Medical Technologies Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $29.43, Kestra Medical Technologies Ltd. has an estimated upside of 20.46% from its current price of $24.43.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $27.00 representing -10.52% downside risk from its current price of $24.43.
Fair Value
-
According to the consensus of 6 analysts, Kestra Medical Technologies Ltd. has 20.46% upside to fair value with a price target of $29.43 per share.
KMTS vs. S&P 500
-
Over the past 5 trading days, Kestra Medical Technologies Ltd. has underperformed the S&P 500 by -1.39% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kestra Medical Technologies Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kestra Medical Technologies Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kestra Medical Technologies Ltd. reported revenues of $22.6M.
Earnings Growth
-
Kestra Medical Technologies Ltd. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Kestra Medical Technologies Ltd. reported earnings per share of -$0.64.
Enterprise value:
1B
EV / Invested capital:
4.95x
Price / LTM sales:
16.89x
EV / EBIT:
--
EV / Revenue:
13.92x
PEG ratio (5yr expected):
-0.22x
EV / Free cash flow:
-9.02x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$34.5M
Return On Assets:
-63.04%
Net Income Margin (TTM):
-177.06%
Return On Equity:
-105.99%
Return On Invested Capital:
-77.65%
Operating Margin:
-140.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | -- | $45.8M | $74.3M | $14.7M | $22.6M | |
| Gross Profit | -$1.9M | $12.3M | $34.5M | $5.8M | $11.4M | |
| Operating Income | -- | -$77.9M | -$129.4M | -$19.1M | -$31.8M | |
| EBITDA | -- | -$35.8M | -$121.3M | -$17.3M | -$29.4M | |
| Diluted EPS | -$1.07 | -$1.89 | -$2.68 | -$0.48 | -$0.64 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $87.9M | $195.4M | |
| Total Assets | -- | -- | -- | $126.1M | $246.7M | |
| Current Liabilities | -- | -- | -- | $31.3M | $35.8M | |
| Total Liabilities | -- | -- | -- | $82.1M | $82.6M | |
| Total Equity | -- | -- | -- | $44M | $164.1M | |
| Total Debt | -- | -- | -- | $46.1M | $44.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$66.3M | -$86.7M | -$18M | -$18.3M | |
| Cash From Investing | -- | -$20.6M | -$10.4M | -$21.6M | -$7.4M | |
| Cash From Financing | -- | $139.8M | $195.6M | $16.5M | -$27K | |
| Free Cash Flow | -- | -$86.9M | -$114.6M | -$22.5M | -$25.8M | |
KMTS
Sector
Market Cap
$1.2B
--
Price % of 52-Week High
81.43%
--
Dividend Yield
0%
--
Shareholder Yield
-15.68%
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$25.95
200-day SMA
Buy
Level
$21.98
Bollinger Bands (100)
Buy
Level
20.54 - 27.46
Chaikin Money Flow
Buy
Level
1.6M
20-day SMA
Sell
Level
$26.41
Relative Strength Index (RSI14)
Sell
Level
41.98
ADX Line
Sell
Level
10.09
Williams %R
Buy
Level
-88.7324
50-day SMA
Sell
Level
$26.18
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
10.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.0491)
Sell
CA Score
(Annual)
Level (-3.0997)
Sell
Beneish M-Score
(Annual)
Level (-1.7818)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (2.5512)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.
Stock Forecast FAQ
In the current month, KMTS has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KMTS average analyst price target in the past 3 months is $29.43.
-
Where Will Kestra Medical Technologies Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kestra Medical Technologies Ltd. share price will rise to $29.43 per share over the next 12 months.
-
What Do Analysts Say About Kestra Medical Technologies Ltd.?
Analysts are divided on their view about Kestra Medical Technologies Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kestra Medical Technologies Ltd. is a Sell and believe this share price will drop from its current level to $27.00.
-
What Is Kestra Medical Technologies Ltd.'s Price Target?
The price target for Kestra Medical Technologies Ltd. over the next 1-year time period is forecast to be $29.43 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KMTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kestra Medical Technologies Ltd. is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KMTS?
You can purchase shares of Kestra Medical Technologies Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kestra Medical Technologies Ltd. shares.
-
What Is The Kestra Medical Technologies Ltd. Share Price Today?
Kestra Medical Technologies Ltd. was last trading at $24.39 per share. This represents the most recent stock quote for Kestra Medical Technologies Ltd.. Yesterday, Kestra Medical Technologies Ltd. closed at $24.43 per share.
-
How To Buy Kestra Medical Technologies Ltd. Stock Online?
In order to purchase Kestra Medical Technologies Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get KMTS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KMTS
Sector
P/E ratio
--
--
PEG ratio
-0.22x
--
P/B ratio
7.09x
--
Price / LTM sales
16.89x
--
Growth Metrics
KMTS
Sector
Revenue growth
53.4%
--
Earnings growth
-33.41%
--
Revenue (5-year growth)
--
--
Earnings forecast
-$0.57
--
Profitability
KMTS
Sector
Profitability FY 2025
$24.2M
--
Return on invested capital
-77.65%
--
Return on assets
-63.04%
--
Return on equity
-105.99%
--
Earnings Date
Last Earnings Date
Dec
11
Next Earnings Date
Mar
17
Estimated Next Earnings Date
Mar
12
Balance Sheet
KMTS
Sector
Total cash
$175.4M
--
Short term investments
--
--
Total assets
$295.7M
--
Long term debt
$44.7M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
